4.7 Article

Targeted removal of migratory tumor cells by functionalized magnetic nanoparticles impedes metastasis and tumor progression

Related references

Note: Only part of the references are listed.
Article Biophysics

A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles

Morteza Mahmoudi et al.

COLLOIDS AND SURFACES B-BIOINTERFACES (2010)

Article Nanoscience & Nanotechnology

Selective removal of ovarian cancer cells from human ascites fluid using magnetic nanoparticles

Kenneth E. Scarberry et al.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2010)

Article Gastroenterology & Hepatology

Acute and long-term gastrointestinal consequences of chemotherapy

Frederic Di Fiore et al.

BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2009)

Article Nanoscience & Nanotechnology

Biodistribution of maltose and gum arabic hybrid gold nanoparticles after intravenous injection in juvenile swine

Genevieve M. Fent et al.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2009)

Article Nanoscience & Nanotechnology

Protracted elimination of gold nanoparticles from mouse liver

Evaldas Sadauskas et al.

NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2009)

Review Oncology

Why does cytotoxic chemotherapy cure only some cancers?

Philip Savage et al.

NATURE CLINICAL PRACTICE ONCOLOGY (2009)

Article Oncology

Cancer statistics, 2008

Ahmedin Jemal et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2008)

Article Chemistry, Multidisciplinary

Magnetic nanoparticle-peptide conjugates for in vitro and in vivo targeting and extraction of cancer cells

Kenneth E. Scarberry et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)

Article Oncology

Endpoints for assessing drug activity in clinical trials

Richard Pazdur

ONCOLOGIST (2008)

Review Oncology

Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures

Romano Demicheli et al.

NATURE CLINICAL PRACTICE ONCOLOGY (2007)

Article Biochemistry & Molecular Biology

Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer

Jeremy R. Chien et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2007)

Article Oncology

CNS metastasis: An old problem in a new guise

Jeanny B. Aragon-Ching et al.

CLINICAL CANCER RESEARCH (2007)

Review Oncology

Ovarian cancer: a focus on management of recurrent disease

Thomas J. Herzog et al.

NATURE CLINICAL PRACTICE ONCOLOGY (2006)

Review Medicine, General & Internal

Mechanisms of disease: Mechanisms of bone metastasis

GD Roodman

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Oncology

EphA2 expression is associated with aggressive features in ovarian carcinoma

PH Thaker et al.

CLINICAL CANCER RESEARCH (2004)

Review Oncology

The current and future management of malignant ascites

EM Smith et al.

CLINICAL ONCOLOGY (2003)

Article Biochemistry & Molecular Biology

An ephrin mimetic peptide that selectively targets the EphA2 receptor

M Koolpe et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2002)

Review Oncology

Dissemination and growth of cancer cells in metastatic sites

AF Chambers et al.

NATURE REVIEWS CANCER (2002)

Article Biochemistry & Molecular Biology

Vascular endothelial growth factor: Acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803

XJ Tian et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)

Article Medicine, Research & Experimental

Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration

S Dias et al.

JOURNAL OF CLINICAL INVESTIGATION (2000)